Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06224855
What this trial is testing

DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsHematological Malignancies
Hangzhou DAC Biotechnology Co., Ltd. 280
Not applicableStudy completedNCT04810052
What this trial is testing

Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 75
Not applicableStudy completedNCT07712835
What this trial is testing

ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis

Who this might be right for
ECMO OutcomesRespiratory Failure (Pediatric Patients)Malignancies, Hematologic+2 more
Children's Mercy Hospital Kansas City 22
Not applicableEnrolling By InvitationNCT05600933
What this trial is testing

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Who this might be right for
Solid TumorsHematologic MalignancyGastrointestinal Cancer+5 more
National Cancer Institute (NCI) 1,200
Large-scale testing (Phase 3)Looking for participantsNCT05768178
What this trial is testing

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

Who this might be right for
Haematological MalignancyMelanomaThyroid Cancer, Papillary+9 more
Cancer Research UK 30
Not applicableLooking for participantsNCT04515810
What this trial is testing

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Hematologic Malignancy+1 more
Fred Hutchinson Cancer Center 400
Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00004258
What this trial is testing

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Indiana University 40
Not applicableStudy completedNCT02464098
What this trial is testing

Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients

Who this might be right for
Diarrhea
St. Jude Children's Research Hospital 200
Not applicableNot Yet RecruitingNCT07234630
What this trial is testing

Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy

Who this might be right for
Hematologic NeoplasmsSolid Tumor Metastatic Cancer Advanced CancerDisseminated Intravascular Coagulation
University Hospital, Strasbourg, France 150
Not applicableLooking for participantsNCT06587100
What this trial is testing

Wearable Activity Tracking to Curb Hospitalizations

Who this might be right for
Hematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm
University of California, San Francisco 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439292
What this trial is testing

Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Ended earlyNCT04214093
What this trial is testing

AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaMultiple Myeloma+1 more
AstraZeneca 9
Testing effectiveness (Phase 2)Ended earlyNCT05100316
What this trial is testing

Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials

Who this might be right for
Neoplasms
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT00465725
What this trial is testing

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+6 more
Poniard Pharmaceuticals 18
Not applicableUnknownNCT01533779
What this trial is testing

Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity

Who this might be right for
Pediatric Solid MalignanciesPediatric Hematological Malignancies
Tel-Aviv Sourasky Medical Center 50
Not applicableEnded earlyNCT03391791
What this trial is testing

Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors

Who this might be right for
Solid and Hematological Malignancies
Adaptimmune 2
Large-scale testing (Phase 3)WithdrawnNCT05403580
What this trial is testing

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Mayo Clinic
Testing effectiveness (Phase 2)WithdrawnNCT06395090
What this trial is testing

Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)

Who this might be right for
Neoplasm Metastasis
Merck Sharp & Dohme LLC
Next Page